Douglas M. Fambrough, III
2015
In 2015, Douglas M. Fambrough, III earned a total compensation of $3.4M as President and Chief Executive Officer at Dicerna Pharmaceuticals, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $229,320 |
|---|---|
| Option Awards | $2,618,710 |
| Salary | $490,000 |
| Other | $16,636 |
| Total | $3,354,666 |
Fambrough received $2.6M in option awards, accounting for 78% of the total pay in 2015.
Fambrough also received $229.3K in non-equity incentive plan, $490K in salary and $16.6K in other compensation.
Rankings
In 2015, Douglas M. Fambrough, III's compensation ranked 2,735th out of 13,638 executives tracked by ExecPay. In other words, Fambrough earned more than 79.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,735 out of 13,638 | 80th |
Division Manufacturing | 964 out of 5,190 | 81st |
Major group Chemicals And Allied Products | 352 out of 1,854 | 81st |
Industry group Drugs | 276 out of 1,528 | 82nd |
Industry Pharmaceutical Preparations | 218 out of 1,182 | 82nd |
Source: SEC filing on May 23, 2017.
Fambrough's colleagues
We found two more compensation records of executives who worked with Douglas M. Fambrough, III at Dicerna Pharmaceuticals in 2015.